PROCYON CORP (PCYN)

Stammdaten

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Clearwater, Florida.

Unternehmen & Branche

NamePROCYON CORP
TickerPCYN
CIK0000812306
BoerseUS
SektorHealthcare
IndustrieDrug Manufacturers - Specialty & Generic
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung1,6 Mio. USD
Beta-1,03
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2024-06-3010-K4,984,433-341,140-0.043,204,4122,287,290
2024-03-3110-Q1,198,539-102,788-0.013,246,6192,249,314
2024-03-3110-K-102,7882,249,314
2023-12-3110-Q1,200,053-242,473-0.033,165,7642,352,102
2023-12-3110-K-242,4732,352,102
2023-09-3010-Q1,173,107-33,855-0.013,438,3782,594,575
2023-09-3010-K-33,8552,594,575
2023-06-3010-K4,686,6597,491-0.013,563,7112,617,709
2023-03-3110-K-29,4712,610,218
2023-03-3110-Q1,124,824-29,4710.003,627,9502,610,218
2022-12-3110-Q1,183,937-20,0780.003,535,3522,639,689
2022-12-3110-K-20,0782,639,689
2022-09-3010-K-8,1872,659,767
2022-09-3010-Q1,175,703-8,1870.003,586,4322,659,767
2022-06-3010-K4,842,433-79,362-0.033,802,4972,667,954
2022-03-3110-Q1,112,498-105,348-0.013,969,3982,747,316
2022-03-3110-K-105,3482,747,316
2021-12-3110-K-67,5622,852,664
2021-12-3110-Q1,330,636-67,562-0.013,855,0492,852,664
2021-09-3010-K42,4822,920,226

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×